Literature DB >> 8232933

Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology.

L I Golbe1, A M Lazzarini, K O Schwarz, M H Mark, D W Dickson, R C Duvoisin.   

Abstract

The few previously reported patients with familial parkinsonism and Lewy-body pathology in the substantia nigra displayed a variety of clinical and pathologic syndromes. We now describe a family with very slowly progressive Parkinson's disease (PD) that has, in most cases, responded poorly to levodopa and includes subjective visual difficult. Four personally confirmed cases--with onset at ages 35, 25, 16, and 16-have occurred in three generations, and four suspicious cases have occurred in three other generations. There has been a trend toward progressively younger age of onset. One autopsied case showed a distribution of cell loss and Lewy bodies typical of PD. The hereditary pattern is most compatible with autosomal dominance. This kindred's illness shows that a presumably single Mendelian dominant gene can cause the clinical and pathologic features of PD, and further extends the clinical spectrum of pathologically typical Lewy-body PD.

Entities:  

Mesh:

Year:  1993        PMID: 8232933     DOI: 10.1212/wnl.43.11.2222

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  A gene for Parkinson's disease?

Authors:  C Hawkes
Journal:  BMJ       Date:  1996-11-23

2.  Familial dementia with Lewy bodies with an atypical clinical presentation.

Authors:  Lauren T Bonner; Debby W Tsuang; Monique M Cherrier; Charisma J Eugenio; Q Du Jennifer; Ellen J Steinbart; Pornprot Limprasert; Albert R La Spada; Benjamin Seltzer; Thomas D Bird; James B Leverenz
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-03       Impact factor: 2.680

Review 3.  Neurogenetic diseases: molecular diagnosis and therapeutic approaches.

Authors:  U Muller; M B Graeber
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

Review 4.  Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.